Characteristics | Overall N = 302 (%) | Remission N = 133 (%) | Failure N = 169 (%) |
---|---|---|---|
Sex | |||
Female | 205 (67.9%) | 104 (78.2%) | 101 (59.8%) |
Male | 97 (32.1%) | 29 (21.8%) | 68 (40.2%) |
Mean Age (± SD) year | 42.8 ± 15.1 | 42.6 ± 14.8 | 42.9 ± 15.5 |
Age group | |||
< 40 years | 133 (44%) | 61 (45.9%) | 72 (42.6%) |
≥ 40 years | 169 (56%) | 72 (54.1%) | 97 (57.4%) |
Thyroid function tests | |||
Median TSH uIU/ml | 0.005 | 0.005 | 0.005 |
(N 0.27–4.2 uIU/ml) | (IQR 0.005–0.01) | (IQR 0.005–0.013) | (IQR 0.005–0.01) |
Median FT3 ng/ml | 14 | 13.8 | 14.8 |
(N 0.93–1.71 ng/ml) | (IQR 8–22.8) | (IQR 6.5–23.1) | (IQR 8.7–22.8) |
Median FT4 pg/ml | 4.6 | 4.3 | 5 |
(N 2.0–4.4 pg/ml) | (IQR 3.1–7.2) | (IQR 2.6–6.7) | (IQR 3.3–7.6) |
TSHa | |||
< 0.01 uIU/ml | 207 (68.5%) | 86 (64.7%) | 121 (71.6%) |
≥ 0.01 uIU/ml | 87 (28.8%) | 42 (31.3%) | 45 (26.6%) |
FT3a | |||
≤ 3UNL | 159 (52.6%) | 74 (55.6%) | 105 (49.3%) |
> 3UNL | 142 (47%) | 59 (44.4%) | 107 (50.2%) |
FT4a | |||
≤ 3UNL | 142 (47%) | 68 (51.1%) | 93 (43.7%) |
> 3UNL | 112 (37.1%) | 44 (33.1%) | 87 (40.8%) |
Extrathyroidal signs | |||
GO | 39 (12.9%) | 17 (12.8%) | 22 (13%) |
Acropachy | 1 (0.3%) | 0 (0%) | 1 (0.6%) |
TPP | 14 (4.6%) | 5 (3.8%) | 9 (5.3%) |
AF | 39 (12.9%) | 16 (12%) | 23 (13.6%) |
Pregnancy | 8 (2.6%) | 2 (1.5%) | 6 (3.6%) |
Severe diseaseb | 25 (8.3%) | 10 (7.5%) | 15 (8.9%) |
Heart failure | 17 (5.6%) | 8 (6%) | 9 (5.3%) |
Hepatitis | 2 (0.7%) | 0 (0%) | 2 (1.2%) |